|Last Price$35.37||Day Change (%)4.96%|
|Open Price$32.92||Day Change ($)1.67|
|Day Range31.55–36.56||52-Week Range31.25–58.46|
As of Thu 2/11/2016 5:00:00 PM | USD
Abbvie expects to bring endometriosis drug to FDA in 2017
Some biotechnology stocks that provide 'clear opportunities,' J.P. Morgan says
On Monday, Neurocrine Biosciences NBIX accelerated its anticipated filing date for indiplon capsules to the second quarter of 2007 instead of 2009. We're placing Neurocrine under review while we revisit our assumptions, and because DOV Pharmaceutical DOVP is entitled to a royalty on any indiplon ...